To the Editor.—
We and other readers of the Archives learned much from Dr Urbach's reply to our recent communication1 in which he precisely out-lined the technical properties and limitations of the xenon arc solarsimulator. However, we addressed ourselves to the clinical report of Mathews-Roth et al2 and to their statement that they were concerned about "a lack of more quantitative correlation" between results obtained with sunlight and the solar simulator for patients with erythropoietic protoporphyria (EPP). We wondered why Mathews-Roth et al employed the solar simulator to evaluate the protective action of β-carotene against long ultraviolet and visible light. Our confusion was somewhat resolved when Dr Pathak (verbal communication, December, 1974) informed us that the instrument had been modified to provide more light energy in the long ultraviolet and visible light regions. The question of whether the modified solar simulator was used appropriately is one
Fusaro RM, Johnson JA. Limited Usefulness of Artificial Light Sources. Arch Dermatol. 1976;112(3):408–409. doi:10.1001/archderm.1976.01630270070019
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.